Judge Says Harvard and Biotech Company 10x Must Face Antitrust Claims in Two Gene Analysis Lawsuits | News
Judge Says Harvard and Biotech Company 10x Must Face Antitrust Claims in Two Gene Analysis Lawsuits | News | The Harvard Crimson
Stay updated with breaking news from Brad Gray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Judge Says Harvard and Biotech Company 10x Must Face Antitrust Claims in Two Gene Analysis Lawsuits | News | The Harvard Crimson
August Issue of Lancet Medical Journal Features Breakthrough Study Decoding Immunological Challenges of Xenotransplantation ...
Operator: Thank you for standing by. My name is Ian, and I will be your conference operator today. At this time, I would like to welcome everyone to the NanoString Q2 2023 Results Conference Call.
SEATTLE, July 11, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States District Court for the District of Delaware in NanoString’s patent litigation with 10x Genomics and President and Fellows of Harvard College. In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirm
10x and Harvard now must defend against allegations that they "are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively" NanoString Technologies,